<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal strictures, either benign or malignant, are not uncommon in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty nine of 1156 <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> patients (5%) admitted to this hospital between 1959 and 1983 developed 70 separate colorectal strictures </plain></SENT>
<SENT sid="2" pm="."><plain>Seventeen of the 70 strictures (24%) proved to be malignant and the other 53 benign </plain></SENT>
<SENT sid="3" pm="."><plain>Nine patients developed more than one stricture </plain></SENT>
<SENT sid="4" pm="."><plain>Three principal features distinguished the 17 malignant from the 53 benign strictures in this series: (1) appearance late in the course of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (61% probability of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in strictures that develop after 20 years of disease v 0% probability in those occurring before 10 years); (2) location proximal to the splenic flexure (86% probability of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> v 47% in sigmoid, 10% in rectum, and 0% in splenic flexure and descending colon); and (3) symptomatic large <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e> (100% probability of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> v only 14% in the absence of obstruction or <z:hpo ids='HP_0002019'>constipation</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated with strictures tends to be more advanced (76% stage D, 24% A and B) than that which does not produce strictures (18% stage D, 59% A and B) </plain></SENT>
</text></document>